石药创新:控股子公司SYS6037注射液(猴痘mRNA疫苗)获得美国药物临床试验批准。
石药创新:控股子公司SYS6037注射液(猴痘mRNA疫苗)获得美国药物临床试验批准。
其他语言标题
- EnglishSimcere Innovation: Its controlled subsidiary's SYS6037 injection (mpox mRNA vaccine) has received U.S. clinical trial approval for investigational drugs.